Malin Inghammar

Malin Inghammar serves as Associate Professor at Lund University's Department of Infection Medicine, Faculty of Medicine, and is a specialist in Infectious Diseases at the Department of Infectious Diseases, Skåne University Hospital. She holds additional affiliations as Project Coordinator for EpiHealth: Epidemiology for Health and as an Affiliated Researcher for Infect@LU. Her academic career bridges clinical practice and epidemiological research with a focus on population-based studies of infectious diseases.

Dr. Inghammar's research interests center on infectious diseases epidemiology, with specific expertise in antimicrobial resistance, severe side effects of antibiotic treatment, microbiology of severe COPD exacerbations, and long-term effects of sepsis. Her work also extends to vaccine acceptance research, particularly regarding COVID-19 vaccination in vulnerable populations. She employs various epidemiological methods including cohort studies, case-control analyses, and population-based surveillance systems to address critical questions in infectious disease management.

Analysis of her recent publications (2025) reveals a strong focus on practical clinical applications of epidemiological research. Her work spans diagnostic microbiology (MALDI-TOF MS libraries), therapeutic interventions (Dornase Alfa for COVID-19), risk factor identification (Aerococcus bloodstream infections), public health implementation (vaccine acceptance), and drug safety (flucloxacillin-induced liver injury). These publications demonstrate her commitment to translating epidemiological findings into actionable clinical knowledge across multiple domains of infectious disease management.

As a research supervisor, Dr. Inghammar currently oversees four doctoral projects, including research on vaccine attitudes in vulnerable populations, pandemic preparedness through large-scale disease surveillance (PREPARE project funded by the Swedish Research Council), early identification of variable immunodeficiency, and the relationship between Streptococcus bovis and gastrointestinal cancer. Her supervisory role extends to both medical and public health research, reflecting the interdisciplinary nature of her work.

Dr. Inghammar leads multiple active research projects, with the PREPARE project representing a significant collaborative effort involving numerous researchers across Lund University. Her work contributes to UN Sustainable Development Goals related to good health and well-being, particularly through her research on antimicrobial resistance and pandemic preparedness. Her research fingerprint shows strong connections to cohort studies, patient care, infection epidemiology, and chronic obstructive pulmonary disease research.